Amendments to Bylaws (Form 8-K)

ITEM 5.03 AMENDMENT TO ARTICLES OF INCORPORATION OR BYLAWS; CHANGE IN FISCAL YEAR.

Effective February 5, 2026, the Board of Directors (the "Board") of KORU Medical Systems, Inc. (the "Company") unanimously adopted a resolution to amend and restate the Company's By-laws in connection with the Securities and Exchange Commission rules regarding universal proxy cards and a periodic review of the bylaws. The changes to the By-laws enhance the existing procedural mechanics and disclosure requirements in connection with stockholder nominations of directors and submission of stockholder proposals made in connection with annual and special meetings of stockholders.

These changes include, without limitation:

• Requiring additional disclosures, representations and acknowledgments from nominating or proposing stockholders, proposed nominees and other persons associated with nominating or proposing stockholders, including regarding compliance with Rule 14a-19 under the Securities Exchange Act of 1934, as amended, with respect to nominating stockholders; and

• Changing the advance notice deadline for stockholders to bring director nominations in the event of an increase in the number of directors under certain circumstances.

A copy of the Amended and Restated By-laws is attached as Exhibit 3.1 hereto and incorporated by reference.